Similarly, a meta-analysis, by Economopoulos et al. examining the association of GST polymorphisms and ovarian cancer risk, suggested that GSTT1, GSTM1, and GSTP1 polymorphisms did not seem to contribute any increased risk in individuals. The gene discussed is GSTM1; the disease is ovarian cancer.